Mallinckrodt Takes $30 Million Deal to End Ohio Opioid Cases
- Company to pay $24 million and donate $6 million in products
- Settlement comes ahead of first federal trial over opioids
Source: Getty Images
This article is for subscribers only.
Mallinckrodt Plc agreed to pay $30 million to settle allegations that it helped fuel the opioid epidemic, avoiding the first federal trial over the addictive painkillers.
The company said in a statement Friday that it will pay $24 million in cash and donate $6 million in generic products, including those used to treat addiction, as part of the settlement. That resolves a case against Mallinckrodt that is scheduled to go to trial next month in Cleveland.